Peptide Therapeutics Market Intelligence Report - Global Forecast 2023-2030

Peptide Therapeutics Market Intelligence Report - Global Forecast 2023-2030

The Global Peptide Therapeutics Market is projected to reach USD 69.56 billion by 2030 from USD 30.10 billion in 2022, at a CAGR 11.03% during the forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions.

In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Peptide Therapeutics Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the Global Peptide Therapeutics Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Technology:

• Hybrid Phase
• Liquid Phase
• Solid Phase

API Type:

• CMO
• In-house

Drug Class:

• Calcitonins
• Glucagon & Analogs
• Insulins
• Luteinizing Hormone-Releasing Hormone
• Somatostatins
• Vasopressin

Application:

• Anti-infective
• Cancer
• Cardio Vascular Disease Respiratory
• Central Nervous System
• Dermatology
• Gastrointestinal
• Metabolic
• Renal

End User:

• Hospitals
• Pharmaceutical Industries
• Research Laboratories

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom